Clincosm LogoSign in Get a demo

Cholangiocarcinoma

Showing NaN - NaN of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

Not yet recruiting
  • Bile Duct Cancer
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 23, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Metastatic Cancer, Solid Tumor, Cholangiocarcinoma Trial in United States (LYT-200, Anti-PD-1, Gemcitabine/nab-paclitaxel)

Recruiting
  • Metastatic Cancer
  • +4 more
  • Phoenix, Arizona
  • +15 more
Mar 9, 2022

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022

Cholangiocarcinoma Trial in Boston (Dasatinib)

Completed
Has Results
  • Cholangiocarcinoma
  • Boston, Massachusetts
  • +1 more
Jul 20, 2020

Cholangiocarcinoma, Hilar Lymphadenopathy, Biliary Stricture Trial in United States (PTBD, ERC)

Terminated
  • Cholangiocarcinoma
  • +2 more
  • PTBD
  • ERC
  • Los Angeles, California
  • +24 more
Mar 23, 2020

Cholangiocarcinoma Trial in Austria, United States (Nab-Paclitaxel and Gemcitabine)

Completed
Has Results
  • Cholangiocarcinoma
  • Nab-Paclitaxel and Gemcitabine
  • Denver, Colorado
  • +24 more
Sep 5, 2018

Carcinoma of Intrahepatic and Extra-hepatic Biliary System, Carcinoma of Gallbladder, Bile Duct Cancer Trial in United States

Completed
  • Carcinoma of Intrahepatic and Extra-hepatic Biliary System
  • +3 more
  • Los Angeles, California
  • +8 more
Sep 6, 2018

Cholangiocarcinoma, Pancreatic Cancer, Bile Duct Cancer Trial in Boston, New York (Radio Frequency ablation Probe)

Unknown status
  • Cholangiocarcinoma
  • +4 more
  • Radio Frequency ablation Probe
  • Boston, Massachusetts
  • +1 more
Feb 16, 2017